Search Results - "Seachrist, D"
-
1
A review of the carcinogenic potential of bisphenol A
Published in Reproductive toxicology (Elmsford, N.Y.) (01-01-2016)“…The estrogenic properties of bisphenol A (BPA), a ubiquitous synthetic monomer that can leach into the food and water supply, have prompted considerable…”
Get full text
Journal Article -
2
The Activin Social Network: Activin, Inhibin, and Follistatin in Breast Development and Cancer
Published in Endocrinology (Philadelphia) (01-05-2019)“…Activins and inhibins are closely related protein heterodimers with a similar tissue distribution; however, these two complexes have opposing functions in…”
Get full text
Journal Article -
3
FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer
Published in Cancers (17-10-2021)“…The pioneering function of FOXA1 establishes estrogen-responsive transcriptomes in luminal breast cancer. Dysregulated FOXA1 chromatin occupancy through focal…”
Get full text
Journal Article -
4
KLF4 defines the efficacy of the epidermal growth factor receptor inhibitor, erlotinib, in triple-negative breast cancer cells by repressing the EGFR gene
Published in Breast cancer research : BCR (18-06-2020)“…Triple-negative breast cancer (TNBC) is characterized by high rates of recurrence and poor overall survival. This is due, in part, to a deficiency of targeted…”
Get full text
Journal Article -
5
UbcH7 regulates 53BP1 stability and DSB repair
Published in Proceedings of the National Academy of Sciences - PNAS (09-12-2014)“…DNA double-strand break (DSB) repair is not only key to genome stability but is also an important anticancer target. Through an shRNA library-based screening,…”
Get full text
Journal Article -
6
Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer
Published in Breast cancer research : BCR (05-06-2017)“…Follistatin (FST) is an intrinsic inhibitor of activin, a member of the transforming growth factor-β superfamily of ligands. The prognostic value of FST and…”
Get full text
Journal Article -
7
Mitotic Vulnerability in Triple-Negative Breast Cancer Associated with LIN9 Is Targetable with BET Inhibitors
Published in Cancer research (Chicago, Ill.) (01-10-2017)“…Triple-negative breast cancers (TNBC) are highly aggressive, lack FDA-approved targeted therapies, and frequently recur, making the discovery of novel…”
Get full text
Journal Article -
8
HER2/ErbB2-induced Breast Cancer Cell Migration and Invasion Require p120 Catenin Activation of Rac1 and Cdc42[S]
Published in The Journal of biological chemistry (17-09-2010)“…Breast cancers that overexpress the receptor tyrosine kinase ErbB2/HER2/Neu result in poor patient outcome because of extensive metastatic progression. Herein,…”
Get full text
Journal Article -
9
Combined SFK/mTOR Inhibition Prevents Rapamycin-Induced Feedback Activation of AKT and Elicits Efficient Tumor Regression
Published in Cancer research (Chicago, Ill.) (01-09-2014)“…Resistance to receptor tyrosine kinase (RTK) blockade in breast cancer is often mediated by activation of bypass pathways that sustain growth. Src and…”
Get full text
Journal Article -
10
LMO4 is an essential mediator of ErbB2 HER2 Neu-induced breast cancer cell cycle progression
Published in Oncogene (15-10-2009)“…ErbB2/HER2/Neu-overexpressing breast cancers are characterized by poor survival due to high proliferation and metastasis rates and identifying downstream…”
Get full text
Journal Article -
11
Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-β signaling in ErbB2/Neu-induced tumors from transgenic mice
Published in Oncogene (04-08-2005)“…Upregulation of HER2/ErbB2/Neu occurs in 15-30% of human breast cancers and correlates with poor prognosis. Identification of ErbB2/Neu transcriptional targets…”
Get full text
Journal Article -
12
double-stranded RNA-binding protein, PACT, is required for postnatal anterior pituitary proliferation
Published in Proceedings of the National Academy of Sciences - PNAS (30-06-2009)“…PACT is a double-stranded RNA-binding protein that also binds and activates the latent protein kinase, PKR, which plays a major role in cellular antiviral…”
Get full text
Journal Article -
13
Krüppel-like Factor 4 Inhibits Tumorigenic Progression and Metastasis in a Mouse Model of Breast Cancer
Published in Neoplasia (New York, N.Y.) (01-07-2011)“…Abstract Krüppel-like factor 4 (KLF4) is a zinc finger transcription factor that functions as an oncogene or tumor suppressor in a highly tissue-specific…”
Get full text
Journal Article -
14
Rapamycin inhibits multiple stages of c-Neu/ErbB2–induced tumor progression in a transgenic mouse model of HER2-positive breast cancer
Published in Molecular cancer therapeutics (01-08-2007)“…Amplification of the HER2 (ErbB2, c-Neu) proto-oncogene in breast cancer is associated with poor prognosis and high relapse rates. HER2/ErbB2, in conjunction…”
Get full text
Journal Article -
15
Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2 Neu-induced tumors
Published in Oncogene (01-06-2006)“…Epidemiological studies indicate that parity enhances HER2/ErbB2/Neu-induced breast tumorigenesis. Furthermore, recent studies using multiparous,…”
Get full text
Journal Article -
16
Chromatin Organization and Transcriptional Programming of Breast Cancer Cell Identity
Published in Endocrinology (Philadelphia) (01-08-2023)“…Abstract The advent of sequencing technologies for assessing chromosome conformations has provided a wealth of information on the organization of the…”
Get full text
Journal Article -
17
GABA(A) Receptor Pi (GABRP) Stimulates Basal-like Breast Cancer Cell Migration through Activation of Extracellular-regulated Kinase 1/2 (ERK1/2)
Published in The Journal of biological chemistry (29-08-2014)“…Breast cancer is a heterogeneous disease comprised of distinct subtypes predictive of patient outcome. Tumors of the basal-like subtype have a poor prognosis…”
Get full text
Journal Article -
18
Reexpression of p8 Contributes to Tumorigenic Properties of Pituitary Cells and Appears in a Subset of Prolactinomas in Transgenic Mice that Hypersecrete Luteinizing Hormone
Published in Molecular endocrinology (Baltimore, Md.) (01-10-2004)“…Targeted overexpression of LH in transgenic mice causes hyperproliferation of Pit-1-positive pituitary cells and development of functional adenomas. To…”
Get full text
Journal Article -
19
Ovarian hyperstimulation induces centrosome amplification and aneuploid mammary tumors independently of alterations in p53 in a transgenic mouse model of breast cancer
Published in Oncogene (13-03-2008)“…Aneuploidy and genomic instability are common features of human cancers, including breast cancer; however, mechanisms by which such abnormalities develop are…”
Get full text
Journal Article -
20
TGF-β/activin signaling promotes CDK7 inhibitor resistance in triple-negative breast cancer cells through upregulation of multidrug transporters
Published in The Journal of biological chemistry (01-10-2021)“…Cyclin-dependent kinase 7 (CDK7) is a master regulatory kinase that drives cell cycle progression and stimulates expression of oncogenes in a myriad of…”
Get full text
Journal Article